Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
Patients with early stage colon cancer benefit from 6 weeks of chemotherapy before surgery
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
JMCC PLUS publishes fundamental and translational research that advances knowledge of the mechanisms for normal and diseased cardiovascular function.
Discovery could lead to new therapies for neurological disorders such as Multiple Sclerosis
School of Pharmacy staff member helping to provide a warm space for the homeless
Researchers who identified a novel mechanism for platelet activation in blood clotting (thrombosis) are now turning their attention to sepsis
Patients, parents, charities and healthcare professionals agree key focuses for future research for disease affecting around half a million in UK
Largest analysis of perinatal outcomes finds disparities in outcomes based on race and ethnicity in high and upper-middle income countries
Across 2022, Professor Jo Morris, from the Institute of Cancer and Genomics, has secured more than £4.9 million to better understand DNA replication and repair.
Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.